세계의 재조합 단백질 시장(2023-2033년)

The global Recombinant Proteins market is projected to grow at a CAGR of 11.1% by 2033

The Recombinant Proteins Market Report 2023-2033: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

The rising prevalence and incidence of chronic illnesses, technological innovation, and expanding R&D investments by key companies are the primary drivers driving the growth of the recombinant proteins market. Increased awareness of chronic illnesses among the general public and governments is predicted to improve the market for recombinant goods. According to the World Health Organisation (WHO), chronic illnesses are the leading cause of mortality worldwide, accounting for over 60% of all fatalities.

The increased frequency of chronic illnesses is one of the major factors impacting the market. Diabetes, cancer, respiratory disorders, and cardiovascular disease are only a handful of the most common chronic diseases. According to Globocan forecasts, the number of cancer cases would rise from 19.3 million in 2020 to 24.6 million in 2030. Furthermore, by 2030, there will be 587 million diabetics globally. Chronic illnesses account for over 80% of mortality in middle- and low-income countries. Chronic illnesses are expected to affect more than 49% of the population in the U.S. by 2025. Strokes and heart problems account for 30% of all fatalities in the U.S.

What Questions Should You Ask before Buying a Market Research Report?

• How is the recombinant proteins market evolving?
  
• What is driving and restraining the recombinant proteins market?
  
• How will each recombinant proteins submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2033?
  
• How will the market shares for each recombinant proteins submarket develop from 2023 to 2033?
  
• What will be the main driver for the overall market from 2023 to 2033?
  
• Will leading recombinant proteins markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
  
• How will the market shares of the national markets change by 2033 and which geographical region will lead the market in 2033?
  
• Who are the leading players and what are their prospects over the forecast period?
  
• What are the recombinant proteins projects for these leading companies?
  
• How will the industry evolve during the period between 2023 and 2033? What are the implications of recombinant proteins projects taking place now and over the next 10 years?
  
• Is there a greater need for product commercialisation to further scale the recombinant proteins market?
  
• Where is the recombinant proteins market heading and how can you ensure you are at the forefront of the market?
  
• What are the best investment options for new product and service lines?
  
• What are the key prospects for moving companies into a new growth path and C-suite?

You need to discover how this will impact the recombinant proteins market today, and over the next 10 years:

• Our 353-page report provides 146 tables and 248 charts/graphs exclusively to you.
  
• The report highlights key lucrative areas in the industry so you can target them - NOW.
  
• It contains in-depth analysis of global, regional and national sales and growth.
  
• It highlights for you the key successful trends, changes and revenue projections made by your competitors.

This report tells you TODAY how the recombinant proteins market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.

Forecasts to 2033 and other analyses reveal commercial prospects

• In addition to revenue forecasting to 2033, our new study provides you with recent results, growth rates, and market shares.
  
• You will find original analyses, with business outlooks and developments.
  
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising recombinant proteins prices and recent developments.

This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, "V", "L", "W" and "U" are discussed in this report.

Segments Covered in the Report

Product & Services Outlook

• Products
  

Cytokines & Growth Factors: Interferons (IFNs), Interleukins (ILs), Others

Antibodies

Enzymes: Kinases Enzymes, Metabolic Enzymes, Others

Recombinant Regulatory Protein

Hormones

Virus Antigens

Immune Checkpoint Proteins

Others

• Services

Application Outlook

• Biopharmaceutical Production
  

Biologics

Vaccines

Cell & Gene Therapies

Others

• Drug Discovery & Development
  
• Research
  
• Diagnostics
  
• Others

Host Cell Outlook

• Mammalian Systems
  
• Bacterial Cells
  
• Yeast & Fungi
  
• Insect Cells
  
• Others

End-user Outlook

• Biopharmaceutical and Biotechnology Companies
  
• CROs
  
• Academic & Research Institutes
  
• Diagnostic Laboratories
  
• Others

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 18 leading national markets:

North America

• U.S.
  
• Canada

Europe

• Germany
  
• UK
  
• France
  
• Spain
  
• Italy
  
• Russia
  
• Rest of Europe

Asia Pacific

• China
  
• Japan
  
• India
  
• Australia
  
• South Korea
  
• Rest of Asia Pacific

Latin America

• Brazil
  
• Mexico
  
• Argentina
  
• Rest of Latin America

MEA

• GCC
  
• South Africa
  
• Rest of MEA

The report also includes profiles and for some of the leading companies in the Recombinant Proteins Market, 2023 to 2033, with a focus on this segment of these companies' operations.

Leading companies and the potential for market growth

• Abcam Plc
  
• Abnova Corporation
  
• Avantor Inc.
  
• Bio-Rad Laboratories, Inc.
  
• Bio-Techne
  
• Enzo Biochem Inc.
  
• GenScript
  
• Merck KGaA
  
• PerkinElmer, Inc.
  
• Proteintech Group, Inc.
  
• RayBiotech Life, Inc.
  
• Sino Biological Inc.
  
• STEMCELL Technologies
  
• Thermo Fisher Scientific Inc.

Overall world revenue for Recombinant Proteins Market, 2023 to 2033 in terms of value the market will surpass US$3,079.9 million in 2023, our work calculates. We predict strong revenue growth through to 2033. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How will the Recombinant Proteins Market, 2023 to 2033 report help you?

In summary, our 350+ page report provides you with the following knowledge:

• Revenue forecasts to 2033 for Recombinant Proteins Market, 2023 to 2033 Market, with forecasts for product & services, application, host cell, end-user, each forecast at a global and regional level - discover the industry's prospects, finding the most lucrative places for investments and revenues.
• Revenue forecasts to 2033 for five regional and 22 key national markets - See forecasts for the Recombinant Proteins Market, 2023 to 2033 market in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
• Prospects for established firms and those seeking to enter the market - including company profiles for 14 of the major companies involved in the Recombinant Proteins Market, 2023 to 2033.

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.

Information found nowhere else

With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Our study is for everybody needing commercial analyses for the Recombinant Proteins Market, 2023 to 2033, market-leading companies. You will find data, trends and predictions.

Table of Contents

1 Report Overview

• 1.1 Objectives of the Study
• 1.2 Introduction to Recombinant Proteins Market
• 1.3 What This Report Delivers
• 1.4 Why You Should Read This Report
• 1.5 Key Questions Answered by This Analytical Report
• 1.6 Who is This Report for?
• 1.7 Methodology
  • 1.7.1 Market Definitions
  • 1.7.2 Market Evaluation & Forecasting Methodology
  • 1.7.3 Data Validation
    • 1.7.3.1 Primary Research
    • 1.7.3.2 Secondary Research
• 1.8 Frequently Asked Questions (FAQs)
• 1.9 Associated Reports
• 1.10 About

2 Executive Summary

3 Market Overview

• 3.1 Key Findings
• 3.2 Market Dynamics
  • 3.2.1 Market Driving Factors
    • 3.2.1.1 Rising Demand for Recombinant Products
    • 3.2.1.2 High Funding for Biomedical Research
    • 3.2.1.3 Increase in Number of Elderly Population will Drive the Market Growth
    • 3.2.1.4 Patent Expiration for Biologics
  • 3.2.2 Market Restraining Factors
    • 3.2.2.1 Price Erosion of Recombinant Proteins
    • 3.2.2.2 Stringent Regulation for Recombinant Proteins Production
  • 3.2.3 Market Opportunities
    • 3.2.3.1 Emerging Economies Expansion and Prioritisation of R&D
    • 3.2.3.2 Growing Significance of Genomics and Proteomics
• 3.3 COVID-19 Impact Analysis
• 3.4 Porter's Five Forces Analysis
  • 3.4.1 Bargaining Power of Suppliers
  • 3.4.2 Bargaining Power of Buyers
  • 3.4.3 Competitive Rivalry
  • 3.4.4 Threat from Substitutes
  • 3.4.5 Threat of New Entrants
• 3.5 PEST Analysis
  • 3.5.1 Political Factors Impacting Recombinant Proteins Market
  • 3.5.2 Economic Factors Impacting Recombinant Proteins Market
  • 3.5.3 Social Factors Impacting Recombinant Proteins Market
  • 3.5.4 Technological Factors Impacting Recombinant Proteins Market

4 Recombinant Proteins Market Analysis by Product & Services

• 4.1 Key Findings
• 4.2 Product & Services Segment: Market Attractiveness Index
• 4.3 Recombinant Proteins Market Size Estimation and Forecast by Product & Services
• 4.4 Products
  • 4.4.1 Market Size by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
  • 4.4.2 Market Share by Region, 2023 & 2033 (%)
  • 4.4.3 Cytokines & Growth Factors
    • 4.4.3.1 Market Size by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
    • 4.4.3.2 Market Share by Region, 2023 & 2033 (%)
    • 4.4.3.3 Interferons (IFNs)
    • 4.4.3.4 Interleukins (ILs)
    • 4.4.3.5 Others
  • 4.4.4 Antibodies
    • 4.4.4.1 Market Size by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
    • 4.4.4.2 Market Share by Region, 2023 & 2033 (%)
  • 4.4.5 Enzymes
    • 4.4.5.1 Enzymes Market Size by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
    • 4.4.5.2 Market Share by Region, 2023 & 2033 (%)
    • 4.4.5.3 Kinases enzymes
    • 4.4.5.4 Metabolic enzymes
    • 4.4.5.5 Other Enzymes
  • 4.4.6 Recombinant Regulatory Protein
    • 4.4.6.1 Market Size by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
    • 4.4.6.2 Market Share by Region, 2023 & 2033 (%)
  • 4.4.7 Hormones
    • 4.4.7.1 Hormones Market Size by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
    • 4.4.7.2 Market Share by Region, 2023 & 2033 (%)
  • 4.4.8 Virus Antigens
    • 4.4.8.1 Market Size by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
    • 4.4.8.2 Market Share by Region, 2023 & 2033 (%)
  • 4.4.9 Immune Checkpoint Proteins
    • 4.4.9.1 Market Size by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
    • 4.4.9.2 Market Share by Region, 2023 & 2033 (%)
  • 4.4.10 Others
    • 4.4.10.1 Market Size by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
    • 4.4.10.2 Market Share by Region, 2023 & 2033 (%)
• 4.5 Services
  • 4.5.1 Service Market Size by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
  • 4.5.2 Market Share by Region, 2023 & 2033 (%)

5 Recombinant Proteins Market Analysis by Application

• 5.1 Key Findings
• 5.2 Application Segment: Market Attractiveness Index
• 5.3 Recombinant Proteins Market Size Estimation and Forecast by Application
• 5.4 Biopharmaceutical Production
  • 5.4.1 Market Size by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
  • 5.4.2 Market Share by Region, 2023 & 2033 (%)
  • 5.4.3 Biologics
    • 5.4.3.1 Market Size by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
    • 5.4.3.2 Market Share by Region, 2023 & 2033 (%)
  • 5.4.4 Vaccines
    • 5.4.4.1 Market Size by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
    • 5.4.4.2 Market Share by Region, 2023 & 2033 (%)
  • 5.4.5 Cell & Gene Therapy
    • 5.4.5.1 Market Size by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
    • 5.4.5.2 Market Share by Region, 2023 & 2033 (%)
  • 5.4.6 Others
    • 5.4.6.1 Market Size by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
    • 5.4.6.2 Market Share by Region, 2023 & 2033 (%)
• 5.5 Drug Discovery & Development
  • 5.5.1 Market Size by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
  • 5.5.2 Market Share by Region, 2023 & 2033 (%)
• 5.6 Research
  • 5.6.1 Research Market Size by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
  • 5.6.2 Market Share by Region, 2023 & 2033 (%)
• 5.7 Diagnostics
  • 5.7.1 Market Size by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
  • 5.7.2 Market Share by Region, 2023 & 2033 (%)
• 5.8 Others
  • 5.8.1 Others Market Size by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
  • 5.8.2 Market Share by Region, 2023 & 2033 (%)

6 Recombinant Proteins Market Analysis by Host Cell

• 6.1 Key Findings
• 6.2 Host Cell Segment: Market Attractiveness Index
• 6.3 Recombinant Proteins Market Size Estimation and Forecast by Host Cell
• 6.4 Mammalian Systems
  • 6.4.1 Market Size by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
  • 6.4.2 Market Share by Region, 2023 & 2033 (%)
• 6.5 Bacterial Cells
  • 6.5.1 Market Size by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
  • 6.5.2 Market Share by Region, 2023 & 2033 (%)
• 6.6 Yeast & Fungi
  • 6.6.1 Market Size by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
  • 6.6.2 Market Share by Region, 2023 & 2033 (%)
• 6.7 Insect Cells
  • 6.7.1 Market Size by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
  • 6.7.2 Market Share by Region, 2023 & 2033 (%)
• 6.8 Others
  • 6.8.1 Market Size by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
  • 6.8.2 Market Share by Region, 2023 & 2033 (%)

7 Recombinant Proteins Market Analysis by End-User

• 7.1 Key Findings
• 7.2 Recombinant Proteins Market Size Estimation and Forecast by End-User
• 7.3 Biopharmaceutical and Biotechnology Companies
  • 7.3.1 Biopharmaceutical and Biotechnology Companies Market Size by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
  • 7.3.2 Market Share by Region, 2023 & 2033 (%)
• 7.4 CROs
  • 7.4.1 Market Size by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
  • 7.4.2 Market Share by Region, 2023 & 2033 (%)
• 7.5 Academic & Research Institutes
  • 7.5.1 Market Size by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
  • 7.5.2 Market Share by Region, 2023 & 2033 (%)
• 7.6 Diagnostic Laboratories
  • 7.6.1 Market Size by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
  • 7.6.2 Market Share by Region, 2023 & 2033 (%)
• 7.7 Others
  • 7.7.1 Market Size by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
  • 7.7.2 Market Share by Region, 2023 & 2033 (%)

8 Recombinant Proteins Market Analysis by Region

• 8.1 Key Findings
• 8.2 Regional Market Size Estimation and Forecast

9 North America Recombinant Proteins Market Analysis

• 9.1 Key Findings
• 9.2 North America Recombinant Proteins Market Attractiveness Index
• 9.3 North America Recombinant Proteins Market by Country, 2023, 2028 & 2033 (US$ Mn)
• 9.4 North America Recombinant Proteins Market Size Estimation and Forecast by Country
• 9.5 North America Recombinant Proteins Market Size Estimation and Forecast by Product &Services
• 9.6 North America Recombinant Proteins Market Size Estimation and Forecast by Product Type
• 9.7 North America Recombinant Proteins Market Size Estimation and Forecast by Cytokines & Growth Factors Type
• 9.8 North America Recombinant Proteins Market Size Estimation and Forecast by Enzymes Type
• 9.9 North America Recombinant Proteins Market Size Estimation and Forecast by Application
• 9.10 North America Recombinant Proteins Market Size Estimation and Forecast by Biopharmaceuticals Production Type
• 9.11 North America Recombinant Proteins Market Size Estimation and Forecast by End-User
• 9.12 North America Recombinant Proteins Market Size Estimation and Forecast by Host Cell
• 9.13 U.S. Recombinant Proteins Market Analysis
• 9.14 Canada Recombinant Proteins Market Analysis

10 Europe Recombinant Proteins Market Analysis

• 10.1 Key Findings
• 10.2 Europe Recombinant Proteins Market Attractiveness Index
• 10.3 Europe Recombinant Proteins Market by Country, 2023, 2028 & 2033 (US$ Mn)
• 10.4 Europe Recombinant Proteins Market Size Estimation and Forecast by Country
• 10.5 Europe Recombinant Proteins Market Size Estimation and Forecast by Product & Services
• 10.6 Europe Recombinant Proteins Market Size Estimation and Forecast by Product Type
• 10.7 Europe Recombinant Proteins Market Size Estimation and Forecast by Cytokines & Growth Factors Type
• 10.8 Europe Recombinant Proteins Market Size Estimation and Forecast by Enzymes Type
• 10.9 Europe Recombinant Proteins Market Size Estimation and Forecast by Application
• 10.10 Europe Recombinant Proteins Market Size Estimation and Forecast by Biopharmaceuticals Production Type
• 10.11 Europe Recombinant Proteins Market Size Estimation and Forecast by End-User
• 10.12 Europe Recombinant Proteins Market Size Estimation and Forecast by Host Cell
• 10.13 Germany Recombinant Proteins Market Analysis
• 10.14 UK Recombinant Proteins Market Analysis
• 10.15 France Recombinant Proteins Market Analysis
• 10.16 Italy Recombinant Proteins Market Analysis
• 10.17 Spain Recombinant Proteins Market Analysis
• 10.18 Russia Recombinant Proteins Market Analysis
• 10.19 Rest of Europe Recombinant Proteins Market Analysis

11 Asia Pacific Recombinant Proteins Market Analysis

• 11.1 Key Findings
• 11.2 Asia Pacific Recombinant Proteins Market Attractiveness Index
• 11.3 Asia Pacific Recombinant Proteins Market by Country, 2023, 2028 & 2033 (US$ Mn)
• 11.4 Asia Pacific Recombinant Proteins Market Size Estimation and Forecast by Country
• 11.5 Asia Pacific Recombinant Proteins Market Size Estimation and Forecast by Product & services
• 11.6 Asia Pacific Recombinant Proteins Market Size Estimation and Forecast by Product Type
• 11.7 Asia Pacific Recombinant Proteins Market Size Estimation and Forecast by Cytokines & Growth Factors Type
• 11.8 Asia Pacific Recombinant Proteins Market Size Estimation and Forecast by Enzymes Type
• 11.9 Asia Pacific Recombinant Proteins Market Size Estimation and Forecast by Application
• 11.10 Asia Pacific Recombinant Proteins Market Size Estimation and Forecast by Biopharmaceuticals Production Type
• 11.11 Asia Pacific Recombinant Proteins Market Size Estimation and Forecast by Host Cell
• 11.12 Asia Pacific Recombinant Proteins Market Size Estimation and Forecast by End-User
• 11.13 Japan Recombinant Proteins Market Analysis
• 11.14 China Recombinant Proteins Market Analysis
• 11.15 India Recombinant Proteins Market Analysis
• 11.16 Australia Recombinant Proteins Market Analysis
• 11.17 South Korea Recombinant Proteins Market Analysis
• 11.18 Rest of Asia Pacific Recombinant Proteins Market Analysis

12 Latin America Recombinant Proteins Market Analysis

• 12.1 Key Findings
• 12.2 Latin America Recombinant Proteins Market Attractiveness Index
• 12.3 Latin America Recombinant Proteins Market by Country, 2023, 2028 & 2033 (US$ Mn)
• 12.4 Latin America Recombinant Proteins Market Size Estimation and Forecast by Product & Services
• 12.5 Latin America Recombinant Proteins Market Size Estimation and Forecast by Product Type
• 12.6 Latin America Recombinant Proteins Market Size Estimation and Forecast by Cytokines & Growth Factors Type
• 12.7 Latin America Recombinant Proteins Market Size Estimation and Forecast by Enzymes Type
• 12.8 Latin America Recombinant Proteins Market Size Estimation and Forecast by Application
• 12.9 Latin America Recombinant Proteins Market Size Estimation and Forecast by Biopharmaceuticals Production Type
• 12.10 Latin America Recombinant Proteins Market Size Estimation and Forecast by End-User
• 12.11 Latin America Recombinant Proteins Market Size Estimation and Forecast by Host Cell
• 12.12 Brazil Recombinant Proteins Market Analysis
• 12.13 Mexico Recombinant Proteins Market Analysis
• 12.14 Argentina Recombinant Proteins Market Analysis
• 12.15 Rest of Latin America Recombinant Proteins Market Analysis

13 MEA Recombinant Proteins Market Analysis

• 13.1 Key Findings
• 13.2 MEA Recombinant Proteins Market Attractiveness Index
• 13.3 MEA Recombinant Proteins Market by Country, 2023, 2028 & 2033 (US$ Mn)
• 13.4 MEA Recombinant Proteins Market Size Estimation and Forecast by Country
• 13.5 MEA Recombinant Proteins Market Size Estimation and Forecast by Product & Services
• 13.6 MEA Recombinant Proteins Market Size Estimation and Forecast by Product Type
• 13.7 MEA Recombinant Proteins Market Size Estimation and Forecast by Cytokines & Growth Factors Type
• 13.8 MEA Recombinant Proteins Market Size Estimation and Forecast by Enzymes Type
• 13.9 MEA Recombinant Proteins Market Size Estimation and Forecast by Application
• 13.10 MEA Recombinant Proteins Market Size Estimation and Forecast by Biopharmaceuticals Production Type
• 13.11 MEA Recombinant Proteins Market Size Estimation and Forecast by End-users
• 13.12 MEA Recombinant Proteins Market Size Estimation and Forecast by End-users
• 13.13 GCC Recombinant Proteins Market Analysis
• 13.14 South Africa Recombinant Proteins Market Analysis
• 13.15 Rest of MEA Recombinant Proteins Market Analysis

14 Company Profiles

• 14.1 Competitive Landscape, 2022
• 14.2 Abcam plc
  • 14.2.1 Company Snapshot
  • 14.2.2 Company Overview
  • 14.2.3 Financial Analysis
    • 14.2.3.1 Net Revenue, 2017-2022
    • 14.2.3.2 Regional Market Shares, 2022
  • 14.2.4 Product Benchmarking
  • 14.2.5 Strategic Outlook
• 14.3 Bio-Techne
  • 14.3.1 Company Snapshot
  • 14.3.2 Company Overview
  • 14.3.3 Financial Analysis
    • 14.3.3.1 Net Revenue, 2017-2022
    • 14.3.3.2 Research & Development, 2017-2022
    • 14.3.3.3 Regional Market Shares, 2022
    • 14.3.3.4 Segmental Market Shares, 2022
  • 14.3.4 Product Benchmarking
  • 14.3.5 Strategic Outlook
• 14.4 GenScript
  • 14.4.1 Company Snapshot
  • 14.4.2 Company Overview
  • 14.4.3 Financial Analysis
    • 14.4.3.1 Net Revenue, 2017-2022
    • 14.4.3.2 Regional Market Shares, 2022
    • 14.4.3.3 Segmental Market Shares, 2021
  • 14.4.4 Product Benchmarking
• 14.5 Bio-Rad Laboratories, Inc.
  • 14.5.1 Company Snapshot
  • 14.5.2 Company Overview
  • 14.5.3 Financial Analysis
    • 14.5.3.1 Net Revenue, 2017-2022
    • 14.5.3.2 Regional Market Shares, 2022
    • 14.5.3.3 Segmental Market Shares, 2022
  • 14.5.4 Product Benchmarking
  • 14.5.5 Strategic Outlook
• 14.6 Merck KGaA
  • 14.6.1 Company Snapshot
  • 14.6.2 Company Overview
  • 14.6.3 Financial Analysis
    • 14.6.3.1 Net Revenue, 2017-2022
    • 14.6.3.2 Research & Development, 2017-2022
    • 14.6.3.3 Regional Market Shares, 2022
    • 14.6.3.4 Segmental Market Shares, 2022
  • 14.6.4 Product Benchmarking
• 14.7 Thermo Fisher Scientific
  • 14.7.1 Company Snapshot
  • 14.7.2 Company Overview
  • 14.7.3 Financial Analysis
    • 14.7.3.1 Net Revenue, 2017-2022
    • 14.7.3.2 Research and Development, 2017-2022
    • 14.7.3.3 Regional Market Shares, 2022
    • 14.7.3.4 Segmental Market Shares, 2022
  • 14.7.4 Product Benchmarking
  • 14.7.5 Strategic Outlook
• 14.8 Enzo Biochem Inc.
  • 14.8.1 Company Snapshot
  • 14.8.2 Company Overview
  • 14.8.3 Financial Analysis
    • 14.8.3.1 Net Revenue, 2017-2022
    • 14.8.3.2 Research & Development, 2017-2022
    • 14.8.3.3 Regional Market Shares, 2022
    • 14.8.3.4 Segmental Market Shares, 2022
  • 14.8.4 Product Benchmarking
• 14.9 Sino Biological, Inc.
  • 14.9.1 Company Snapshot
  • 14.9.2 Company Overview
  • 14.9.3 Product Benchmarking
• 14.10 Proteintech Group, Inc
  • 14.10.1 Company Snapshot
  • 14.10.2 Company Overview
  • 14.10.3 Product Benchmarking
• 14.11 Abnova Corporation
  • 14.11.1 Company Snapshot
  • 14.11.2 Company Overview
  • 14.11.3 Product Benchmarking
• 14.12 RayBiotech Life, Inc.
  • 14.12.1 Company Snapshot
  • 14.12.2 Company Overview
  • 14.12.3 Product Benchmarking
• 14.13 STEMCELL Technologies
  • 14.13.1 Company Snapshot
  • 14.13.2 Company Overview
  • 14.13.3 Product Benchmarking
• 14.14 PerkinElmer Inc.
  • 14.14.1 Company Snapshot
  • 14.14.2 Company Overview
  • 14.14.3 Financial Analysis
    • 14.14.3.1 Net Revenue, 2017-2022
    • 14.14.3.2 Research & Development, 2017-2022
    • 14.14.3.3 Regional Market Shares, 2022
    • 14.14.3.4 Segmental Market Shares, 2022
  • 14.14.4 Product Benchmarking
  • 14.14.5 Strategic Outlook
• 14.15 Avantor Inc.
  • 14.15.1 Company Snapshot
  • 14.15.2 Company Overview
  • 14.15.3 Financial Analysis
    • 14.15.3.1 Net Revenue, 2017-2022
    • 14.15.3.2 Regional Market Shares, 2022
  • 14.15.4 Product Benchmarking
  • 14.15.5 Strategic Outlook

15 Conclusion and Recommendations

• 15.1 Concluding Remarks from
• 15.2 Recommendations for Market Players